Innate protection from graft-versus-host disease

Blood

Volumn 124, Issue 5, 2014, Pages 673-675

  Cupedo, Tom ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; TOLL LIKE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; BACTERIAL TRANSLOCATION; CANCER CHEMOTHERAPY; CELL HOMING; COMMENSALISM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HELPER CELL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; INNATE IMMUNITY; INNATE LYMPHOID CELL; LUNG INJURY; LYMPHOID CELL; MICROFLORA; MONOCYTE; NEUTROPHIL; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; TISSUE INJURY; TISSUE REPAIR;

ANIMALS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, INNATE; LEUKEMIA; LYMPHOCYTES; MALE; MUCOSITIS;

EID: 84905118907     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-578971     Document Type: Note

References (11)

1. Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5):700-709.
2. Munneke JM, Björklund AT, Mjösberg JM, et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood. 2014;124(5):812-821.
3. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145-149.
4. Cornelissen F, Aparicio Domingo P, Reijmers RM, Cupedo T. Activation and effector functions of human RORC1 innate lymphoid cells. Curr Opin Immunol. 2011;23(3):361-367.
5. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722-725.
6. Kim BS, Siracusa MC, Saenz SA, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med. 2013;5:170ra116.
7. Ljungman P, Bregni M, Brune M, et al European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 2010;45(2):219-234.
8. Socié G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-4336.
9. Penack O, Holler E, van den Brink MR. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood. 2010;115(10):1865-1872.
10. Hanash AM, Dudakov JA, Hua G, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 2012;37(2):339-350.
11. Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045-1054.